X
X

Helsinn R&D Capabilities - PIPELINE

The investigational uses for these compounds have not been established and are not approved for commercial use in the United States.

* Managed by Helsinn’s partner in Japan: Taiho Pharmaceutical
*** Managed by Helsinn’s partner in Japan: ONO-Pharmaceutical

** NSCLC (Non-Small Cell Lung Cancer)


The investigational uses for these compounds have not been established and are not approved for commercial use worldwide.

**** Managed by MEI Pharma on behalf of Helsinn
***** Co-development with Taiho Pharmaceutical